Concepedia

Shu-Ting Pan

SP

Statistics

Publications

3

Citations

194

H-Index

3

Active since

2015

Affiliations

Guiyang Medical University(Current)

Nanchang University

University of Utah

Ningxia Medical University

University of South Florida

Shu-Ting Pan is an author at Guiyang Medical University specializing in molecular oncology, oncology, and anticancer activity.

Publications per year

2015–2015

3

Publications

3

Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells

Shu-Feng Zhou, Shu-Ting Pan, Yiru Qin et al. · Drug Design Development and Therapy · 2015 · 115 citations · Full text

, , +17

Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells

Shu-Feng Zhou, Feng Wang, Hai Li et al. · Drug Design Development and Therapy · 2015 · 60 citations · Full text

, , +17

Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach

Shu‐Feng Zhou, Shu-Ting Pan, Zhiwei Zhou et al. · Drug Design Development and Therapy · 2015 · 19 citations · Full text

, , +14

1–3 of 3